Granules India Ltd is strengthening oversight at its manufacturing facilities and digitising key records after the U.S. Food and Drug Administration flagged compliance issues at its largest plant in Telangana. The regulator had pointed out lapses in record-keeping, equipment cleaning, and contamination controls, including the discovery of torn data records in waste bags. Continue Reading
